A startup that uses artificial intelligence to discover new drugs just landed a $2 billion valuation

BenevolentAI, a UK-based startup that uses artificial intelligence to discover new treatments just raised $115 million. The funding, which came from existing investors including Woodford Investment Management, values the six-year-old company at $2 billion, a unicorn status held by only a few biotech ...
à

Kickstarter's focus is on engaging with creative people: Perry Chen

AI ( artificial intelligence ) is one of the biggest changes. We've been dealing with how tech affects us for the past 10-20 years. But ...